Rhesus macaque myeloid-derived suppressor cells demonstrate t cell inhibitory functions and are transiently increased after vaccination

Journal of Immunology

Volumn 200, Issue 1, 2018, Pages 286-294

  Lin, Ang ^a,b   Liang, Frank ^a,b   Thompson, Elizabeth A ^a,b   Vono, Maria ^a,b   Ols, Sebastian ^a,b   Lindgren, Gustaf ^a,b   Hassett, Kimberly ^c   Salter, Hugh ^b   Ciaramella, Giuseppe ^c   Loré, Karin ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Valera LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; ARGINASE 1; CD11B ANTIGEN; CD14 ANTIGEN; CD33 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR2; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOOXYGENASE 2; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PROGRAMMED DEATH 1 LIGAND 1; ARGINASE; ARGINASE I, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARGINASE 1 GENE; ARTICLE; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; COX 2 GENE; CYTOKINE PRODUCTION; CYTOPLASM; DOWN REGULATION; HUMAN; HUMAN CELL; IDO1 GENE; IL 10 GENE; IL 1BETA GENE; IL 6 GENE; IN VITRO STUDY; INFLUENZA VACCINATION; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MONOCYTE; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PDL1 GENE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; UPREGULATION; ANIMAL; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H10N8); METABOLISM; MICROARRAY ANALYSIS; NEUTROPHIL; ORTHOMYXOVIRUS INFECTION; T LYMPHOCYTE; VACCINATION;

ANIMALS; ARGINASE; B7-H1 ANTIGEN; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLUENZA A VIRUS, H10N8 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERLEUKIN-10; MACACA MULATTA; MICROARRAY ANALYSIS; MYELOID-DERIVED SUPPRESSOR CELLS; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; SIALIC ACID BINDING IG-LIKE LECTIN 3; T-LYMPHOCYTES; VACCINATION;

EID: 85038583616     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1701005     Document Type: Article

References (40)

1. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
2. Ostrand-Rosenberg, S., P. Sinha, D. W. Beury, and V. K. Clements. 2012. Crosstalk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin. Cancer Biol. 22: 275-281.
3. Bronte, V., S. Brandau, S. H. Chen, M. P. Colombo, A. B. Frey, T. F. Greten, S. Mandruzzato, P. J. Murray, A. Ochoa, S. Ostrand-Rosenberg, et al. 2016. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7: 12150.
4. Sui, Y., A. Hogg, Y. Wang, B. Frey, H. Yu, Z. Xia, D. Venzon, K. McKinnon, J. Smedley, M. Gathuka, et al. 2014. Vaccine-induced myeloid cell population dampens protective immunity to SIV. J. Clin. Invest. 124: 2538-2549.
5. Sui, Y., B. Frey, Y. Wang, R. Billeskov, S. Kulkarni, K. McKinnon, T. Rourke, L. Fritts, C. J. Miller, and J. A. Berzofsky. 2017. Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques. PLoS Pathog. 13: e1006395.
6. Sagiv, J. Y., J. Michaeli, S. Assi, I. Mishalian, H. Kisos, L. Levy, P. Damti, D. Lumbroso, L. Polyansky, R. V. Sionov, et al. 2015. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Reports 10: 562-573.
7. Dumitru, C. A., K. Moses, S. Trellakis, S. Lang, and S. Brandau. 2012. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol. Immunother. 61: 1155-1167.
8. Kumar, V., S. Patel, E. Tcyganov, and D. I. Gabrilovich. 2016. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 37: 208-220.
9. Shah, K. H., P. Shi, J. F. Giani, T. Janjulia, E. A. Bernstein, Y. Li, T. Zhao, D. G. Harrison, K. E. Bernstein, and X. Z. Shen. 2015. Myeloid suppressor cells accumulate and regulate blood pressure in hypertension. Circ. Res. 117: 858-869.
10. Pastuła, A., and J. Marcinkiewicz. 2011. Myeloid-derived suppressor cells: a double-edged sword? Int. J. Exp. Pathol. 92: 73-78.
11. Sibal, L. R., and K. J. Samson. 2001. Nonhuman primates: a critical role in current disease research. ILAR J. 42: 74-84.
12. Bahl, K., J. J. Senn, O. Yuzhakov, A. Bulychev, L. A. Brito, K. J. Hassett, M. E. Laska, M. Smith, O. Almarsson, J. Thompson, et al. 2017. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol. Ther. 25: 1316-1327.
13. Liang, F., A. Ploquin, J. D. Hernández, H. Fausther-Bovendo, G. Lindgren, D. Stanley, A. S. Martinez, J. M. Brenchley, R. A. Koup, K. Loré, and N. J. Sullivan. 2015. Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques. J. Immunol. Methods 425: 69-78.
14. Vono, M., A. Lin, A. Norrby-Teglund, R. A. Koup, F. Liang, and K. Lore. 2017. Neutrophils acquire the capacity for antigen presentation to memory CD4+ T cells in vitro and ex vivo. Blood 129: 1991-2001.
15. Nauseef, W. M. 2014. Isolation of human neutrophils from venous blood. Methods Mol. Biol. 1124: 13-18.
16. Sugimoto, C., A. Hasegawa, Y. Saito, Y. Fukuyo, K. B. Chiu, Y. Cai, M. W. Breed, K. Mori, C. J. Roy, A. A. Lackner, et al. 2015. Differentiation kinetics of blood monocytes and dendritic cells in macaques: insights to understanding human myeloid cell development. J. Immunol. 195: 1774-1781.
17. Scapini, P., O. Marini, C. Tecchio, and M. A. Cassatella. 2016. Human neutrophils in the saga of cellular heterogeneity: insights and open questions. Immunol. Rev. 273: 48-60.
18. Elghetany, M. T. 2002. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol. Dis. 28: 260-274.
19. Cravens, P. D., K. Hayashida, L. S. Davis, T. Nanki, and P. E. Lipsky. 2007. Human peripheral blood dendritic cells and monocyte subsets display similar chemokine receptor expression profiles with differential migratory responses. Scand. J. Immunol. 65: 514-524.
20. Lesokhin, A. M., T. M. Hohl, S. Kitano, C. Cortez, D. Hirschhorn-Cymerman, F. Avogadri, G. A. Rizzuto, J. J. Lazarus, E. G. Pamer, A. N. Houghton, et al. 2012. Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res. 72: 876-886.
21. Rotondo, R., M. Bertolotto, G. Barisione, S. Astigiano, S. Mandruzzato, L. Ottonello, F. Dallegri, V. Bronte, S. Ferrini, and O. Barbieri. 2011. Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation. J. Leukoc. Biol. 89: 721-727.
22. Rodriguez, P. C., M. S. Ernstoff, C. Hernandez, M. Atkins, J. Zabaleta, R. Sierra, and A. C. Ochoa. 2009. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69: 1553-1560.
23. Lechner, M. G., D. J. Liebertz, and A. L. Epstein. 2010. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185: 2273-2284.
24. Obermajer, N., R. Muthuswamy, J. Lesnock, R. P. Edwards, and P. Kalinski. 2011. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 118: 5498-5505.
25. Zahorchak, A. F., M. B. Ezzelarab, L. Lu, H. R. Turnquist, and A. W. Thomson. 2016. In vivo mobilization and functional characterization of nonhuman primate monocytic myeloid-derived suppressor cells. Am. J. Transplant. 16: 661-671.
26. Liang, F., G. Lindgren, K. J. Sandgren, E. A. Thompson, J. R. Francica, A. Seubert, E. De Gregorio, S. Barnett, D. T. O'Hagan, N. J. Sullivan, et al. 2017. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake. Sci. Transl. Med. 9: eaal2094.
27. Liang, F., G. Lindgren, A. Lin, E. A. Thompson, S. Ols, J. Rohss, S. John, K. Hassett, O. Yuzhakov, K. Bahl, et al. 2017. Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques. Mol. Ther. In press.
28. Marini, O., S. Costa, D. Bevilacqua, F. Calzetti, N. Tamassia, C. Spina, D. De Sabata, E. Tinazzi, C. Lunardi, M. T. Scupoli, et al. 2017. Mature CD10(+) and immature CD10(-) neutrophils present in G-CSF-treated donors display opposite effects on T cells. Blood 129: 1343-1356.
29. Darcy, C. J., G. Minigo, K. A. Piera, J. S. Davis, Y. R. McNeil, Y. Chen, A. D. Volkheimer, J. B. Weinberg, N. M. Anstey, and T. Woodberry. 2014. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit. Care 18: R163.
30. Brandau, S., K. Moses, and S. Lang. 2013. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins? Semin. Cancer Biol. 23: 171-182.
31. Kotsakis, A., M. Harasymczuk, B. Schilling, V. Georgoulias, A. Argiris, and T. L. Whiteside. 2012. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J. Immunol. Methods 381: 14-22.
32. Youn, J. I., and D. I. Gabrilovich. 2010. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40: 2969-2975.
33. Wang, J., Y. Shirota, D. Bayik, H. Shirota, D. Tross, J. L. Gulley, L. V. Wood, J. A. Berzofsky, and D. M. Klinman. 2015. Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells. J. Immunol. 194: 4215-4221.
34. Cripps, J. G., and J. D. Gorham. 2011. MDSC in autoimmunity. Int. Immunopharmacol. 11: 789-793.
35. Le Blanc, K., R. Jitschin, and D. Mougiakakos. 2013. Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation: a double-edged sword? OncoImmunology 2: e25009.
36. Liang, F., and K. Loré. 2016. Local innate immune responses in the vaccine adjuvant-injected muscle. Clin. Transl. Immunology 5: e74.
37. Fernández, A., L. Oliver, R. Alvarez, L. E. Fernández, K. P. Lee, and C. Mesa. 2014. Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination. Hum. Vaccin. Immunother. 10: 3251-3260.
38. Malmberg, K. J. 2004. Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape? Cancer Immunol. Immunother. 53: 879-892.
39. Lapphra, K., and D. Scheifele. 2009. Vaccination site reaction or bacterial cellulitis? Paediatr. Child Health 14: 245.
40. von Elten, K. A., L. L. Duran, T. A. Banks, T. A. Banks, L. C. Collins, and L. C. Collins. 2014. Systemic inflammatory reaction after pneumococcal vaccine: a case series. Hum. Vaccin. Immunother. 10: 1767-1770.